Form D · Other

Vantis Vascular, Inc.

San Jose, CA · CIK 0001761882

Offering snapshot reported Jul 10, 2026 · SEC filing

Reported sold: $18.6M
Investors reported: 123
Minimum accepted: $0
First sale: Jun 26, 2026

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 10, 2026	Initial	$18,639,500	No comparison	123	SEC filing
Oct 10, 2024	Initial	$14,338,798	No comparison	114	SEC filing
Feb 4, 2022	Initial	$7,043,766	No comparison	73	SEC filing
Sep 7, 2021	Initial	$503,500	No comparison	Not reported	SEC filing
Dec 14, 2020	Initial	$700,000	No comparison	20	SEC filing
Dec 18, 2018	Initial	$485,000	No comparison	14	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-590303

Of the total amount sold, $8,639,500 relates to new money investments, and $10,000,000 relates to shares issued for the conversion of SAFEs. The amount sold does not include up to $1,295,924 to be received upon exercise of warrants issued in the offering.

Source: Form D, filed Jul 10, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Tim Fischell	Director, Executive
Gary Mc Cord	Executive
Mike Mirizzi	Executive
Marc Monahan	Executive
Len Pinchuk	Director
Frank Saltiel	Director, Executive
Jason Turner	Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:

2570 N 1 St Street Suite 200
San Jose, CA, 95131